ChulaCov19 vaccine

SARS-Cov2 Wild-type S-spike mRNA/lipid nanoparticle (LNP) vaccine

Also Known As:

ChulaCov19; ChulaCov19 COVID-19 vaccine

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Viremia 01/01/2023 - "Challenge studies show that ChulaCov19 protects human-ACE-2-expressing female mice from COVID-19 symptoms, prevents viremia and significantly reduces tissue viral load. "
2.	COVID-19 01/01/2023 - "Challenge studies show that ChulaCov19 protects human-ACE-2-expressing female mice from COVID-19 symptoms, prevents viremia and significantly reduces tissue viral load. "